Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.59p
   
  • Change Today:
      0.030p
  • 52 Week High: 2.61
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 181,321
  • Market Cap: £6.62m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £23,666
Lisa Baderoon 583,963 £9,285
Tim Franklin 525,000 £8,348

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 41,620,407 £661,764
Luca & Associates AG 22,000,000 £349,800
Invesco Ltd 17,872,341 £284,170
Aviva Investors Global 11,285,180 £179,434
Alora Pharmaceuticals LLC 10,909,091 £173,454
M&G Investments 7,600,000 £120,840
Prudential plc 7,600,000 £120,840
Capital Income Builder 4,870,367 £77,439
Dr R Zimmer 4,551,553 £72,370
Odey Asset Management 3,433,319 £54,590
Rhone Trustees (Switzerland) SA 3,386,000 £53,837
Pictet Overseas Trust Corporation Limited 3,287,500 £52,271

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.59p
Change Today 0.030p
% Change 1.92 %
52 Week High 2.61
52 Week Low 0.85
Volume 181,321
Shares Issued 416.44m
Market Cap £6.62m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.13% below the market average71.13% below the market average71.13% below the market average71.13% below the market average71.13% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Price Trend
62.97% below the market average62.97% below the market average62.97% below the market average62.97% below the market average62.97% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 31-Oct-2024

Time Volume / Share Price
16:35 2,000 @ 1.59p
16:35 2,000 @ 1.59p
16:29 12,174 @ 1.61p
16:04 22,215 @ 1.59p
15:43 5,000 @ 1.59p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page